Covered recipient · General Payments record
JOHN M BUTLER
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2023
$1,973.67
- Reported across 121 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $225.18 | 10 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $108.52 | 4 |
| ABBVIE INC. | $39.14 | 2 |
| Lilly USA, LLC | $38.43 | 2 |
| Abbott Laboratories | $20.67 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $18.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.67 | 02/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018767833 | CMS |
| AbbVie Inc. | $25.61 | 02/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996340559 | CMS |
| AbbVie Inc. | $13.53 | 06/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996340561 | CMS |
| GlaxoSmithKline, LLC. | $34.79 | 02/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001352895 | CMS |
| GlaxoSmithKline, LLC. | $24.69 | 06/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001352907 | CMS |
| GlaxoSmithKline, LLC. | $20.86 | 08/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001352973 | CMS |
| GlaxoSmithKline, LLC. | $28.18 | 08/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001353021 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $18.42 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034504701 | CMS |
| Lilly USA, LLC | $15.48 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031680581 | CMS |
| Lilly USA, LLC | $22.95 | 06/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031516131 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.